𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells

✍ Scribed by Arun Rajgopal; Daniel W. Young; Khawaja A. Mujeeb; Janet L. Stein; Jane B. Lian; Andre J. van Wijnen; Gary S. Stein

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
208 KB
Volume
100
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Skeletal development and osteoblast maturation require the phenotype promoting activity of the transcription factor RUNX2, which controls both cell growth and differentiation in osteoblasts. We have recently shown that in actively proliferating cells RUNX2 regulates the expression of specific target genes as cells enter and exit mitosis. In this study, we addressed whether post‐translational modifications of RUNX2 control its activity during mitotic exit. Western blot analysis of proteins from osteoblastic Saos‐2 cells released from mitotic inhibition into early G~1~ show a phosphatase‐sensitive shift in the mobility of RUNX2 in SDS gels. The slowly migrating hyper‐phosphorylated form of RUNX2 is immunoreactive with a CDK related phospho‐antibody (MPM2) only in mitotic cells and is converted into a faster migrating hypo‐phosphorylated RUNX2 when cells complete mitosis. This conversion is inhibited by okadaic acid, an inhibitor of protein phosphatases 1 and 2 (PP1 and PP2A), but not by deltamethrin which blocks PP2B phosphatase. Mitotic phosphorylation of RUNX2 is sensitive to the CDK inhibitors roscovitine and olomoucine. Furthermore, RUNX2 can directly interact with CDK1 and is phosphorylated in vitro by the CDK1/cyclin B kinase complex. Hence, RUNX2 is hyper‐phosphorylated by CDK1/cyclin B during mitosis, and dynamically converted into a hypo‐phosphorylated form by PP1/PP2A‐dependent dephosphorylation after mitosis to support the post‐mitotic regulation of RUNX2 target genes. J. Cell. Biochem. 100: 1509–1517, 2007. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Loss of Cyclin B1 followed by downregula
Loss of Cyclin B1 followed by downregulation of Cyclin A/Cdk2, apoptosis and antiproliferation in Hela cell line
✍ Xian He Xie; Hee Jung An; Suki Kang; Sunghui Hong; Yoon Pyo Choi; Young Tae Kim; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 272 KB

## Abstract Recent studies have shown that Cyclin B1 is overexpressed in various tumor types but present at low levels in normal tissues. To explore the possibility of employing Cyclin B1 as an anticancer target, we knocked down Cyclin B1 in an HeLa cell line using RNA interference (RNAi). Subseque

Selective induction of cell cycle regula
Selective induction of cell cycle regulatory genes cdk1 (p34cdc2), cyclins a/b, and the tumor suppressor gene RB in transformed cells by okadaic acid
✍ Jinsong You; R. Curtis Bird 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 962 KB

Genes encoding cdkl (~34'~''), cyclin A, cyclin B, and the tumor suppressor gene Rb are fundamental regulators of cell cycle progression which associate as a complex with the transcription factor E2F. Expression of many of these proteins has previously been shown to be repressed by okadaic acid, a s